Stroke COunseling for Risk REduction (SCORRE)

December 11, 2018 updated by: Dawn Aycock, Georgia State University

Stroke Counseling for Risk Reduction in Young Adult African Americans

The purpose of this study is to test the efficacy of the Stroke Counseling for Risk Reduction (SCORRE) intervention in increasing accuracy of perceived stroke risk and promoting lifestyle behavior change to reduce stroke risk in young adult African Americans.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

116

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Georgia
      • Atlanta, Georgia, United States, 30294
        • Georgia State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • self-identify as African American/Black
  • age 20-35 years
  • able to complete two study visits lasing 1 1/2- 2 hours and a brief daily diary for 8 weeks
  • has a cell phone or email address to receive weekly reminders and tips
  • has at least one modifiable risk factor for stroke identified during study visit one screening

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: SCORRE group
Stroke risk factor brochure, stroke champions video, counseling on accuracy of perceived stroke risk and strategies to reduce stroke risk, weekly motivational health behavior tips (for physical activity, diet, or smoking cessation) text messages for 8 weeks.
Behavioral: SCORRE
3 components based on the Health Belief Model
SHAM_COMPARATOR: Attention Control Group
Sexual health education brochure and Safe in the City video, weekly sexual health tips text messages for 8 weeks.
Behavioral: Attention-Control Activity
sexual health education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of perceived stroke risk
Time Frame: immediately post-intervention
Comparison of perceived versus actual stroke risk
immediately post-intervention
Targeted health behaviors
Time Frame: 8 weeks
Improvements in targeted health behavior (physical activity, diet, or cigarette smoking)
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Georgia State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 1, 2017

Primary Completion (ACTUAL)

December 20, 2017

Study Completion (ACTUAL)

December 20, 2017

Study Registration Dates

First Submitted

March 5, 2017

First Submitted That Met QC Criteria

March 5, 2017

First Posted (ACTUAL)

March 10, 2017

Study Record Updates

Last Update Posted (ACTUAL)

December 13, 2018

Last Update Submitted That Met QC Criteria

December 11, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • K01NR015494 (NIH)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe